Viveka Hiort af Ornäs resigns as Chief Finance Officer at Ortivus

Ortivus announces that Viveka Hiort af Ornäs, the company's Chief Financial Officer, is leaving Ortivus to pursue new opportunities outside the organization.

Viveka Hiort af Ornäs, who has been with Ortivus since 2022, has decided to step down from her roles as the company's Chief Financial Officer and as a member of the management team. Viveka will continue with the company until 2024-07-12, and the process to recruit a new CFO will now begin.

“During her time at Ortivus, Viveka has strengthened our financial strategies and significantly improved our processes. We are grateful for her dedicated efforts and wish her the best of luck in her future career endeavors.” Says Gustaf Nordenhök, CEO of Ortivus.

About Ortivus

Ortivus develops and commercialises MobiMed, e-health and medical technology solutions for a safer and more efficient healthcare. The company was founded in 1985 and is today a leading provider of mobile digital solutions for prehospital care, worldwide. Ortivus' innovations are based on in-depth expertise in cardiology as well as decades of development together with users and customers. The company's headquarters are located in Danderyd, Stockholm. The company has, since 1998, a wholly owned subsidiary based in the United Kingdom and since 2022, a wholly owned subsidiary based in Denmark.

MobiMed is a modular platform that connects and enable real-time information sharing throughout the prehospital care chain. It is currently used by over 12,000 paramedics in over 2,700 emergency vehicles. The platform, MobiMed, consists of several product modules that are completely integrated but can also be used stand-alone. MobiMed comprises four main solutions: MobiMed Monitor, that measures, monitors and shares patients' vital parameters and ECG in real-time, MobiMed ePR, – an electronic patient record for decision support, collection of patient data and clinical documentation, MobiMed enRoute, – a tool for navigation and case management, and MobiMed Life – a range of stand-alone defibrillators.

MobiMed saves vital seconds and enable healthcare professionals make the right decisions in critical situations. MobiMed also contributes to improved quality of care and saved resources.

Ortivus Class A and Class B shares are listed on the NASDAQ Stockholm Small Cap list.

Read more about Ortivus at www.ortivus.com